Hemophilia recognized as a disorder characterized by excessive bleeding, has...
André De Almeida, PhD student at the University Hospital Ghent presented his...
Dr Fred Locke from Moffitt Cancer Center in Florida shares the data that were...
We take pleasure in presenting the third daily highlight from the ASH 2023...
The current standard of care for patients with NDMM involves four cycles of VRd...
The ZUMA-12 study represents a phase 2 clinical trial aimed at investigating...
Allogeneic CAR T-cell therapies represent a potentially readily accessible...
The therapeutic potential of inhibiting NETs in various pathological conditions...
Dr Sharman presents the 6-year follow-up outcomes of the ELEVATE-TN study, a...
Dr Rutger Callens, a haematologist at AZ Delta in Roeselare, graciously...